Accomplished global commercial leader with deep expertise in retina drug launches Primary architect for the industry-defining ...
US ophthalmology specialist Ocular Therapeutix announced that David Robinson has agreed to join the company as global chief commercial officer (CCO).
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback